Compare Nasdaq100 ETF (QQQ) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Nasdaq100 ETFTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Nasdaq100 ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Nasdaq100 ETF trades at $704.38, while State Street SPDR S&P Biotech ETF trades at $152.06. Which is the better fit depends on your goals.

	QQQ	XBI
52-Week High	$746.16	$164.28
52-Week Low	$553.88	$85.16
Sector	—	Broad Market / Factor

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nasdaq100 ETF

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $150.94, down 2.14% today, with technical indicators showing a bearish trend but oversold RSI suggesting potential near-term support. The ETF lacks traditional valuation metrics due to its structure, but recent news highlights strong biotech sector momentum, including a 17% monthly gain and robust M&A activity. Analyst coverage is limited to a single hold rating, reflecting cautious optimism amid sector volatility.

Outlook: Biotech sector tailwinds from M&A and AI-driven drug discovery offer upside, but high volatility and policy risks persist. Investors should weigh XBI's equal-weight exposure to small/mid-cap biotech against its elevated beta, with technical support near $149 critical for short-term direction.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

QQQ

Equal-weighted ETFs gain attention as Q2 earnings growth broadens beyond tech giantsETF Trends · 15 hours agoBullish iShares Nasdaq Top 30 ETF outperforms QQQ with a 30% return by focusing on mega-cap tech giants.24/7 Wall Street · 3 days agoBullish REX AI Equity Premium Income ETF offers 36.5% yield but caps upside and may return capital.24/7 Wall Street · 4 days agoNeutral View details →

XBI

View details →

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.